Kalvista Pharmaceuticals, Inc. (KALV) — 10-K Filings
All 10-K filings from Kalvista Pharmaceuticals, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
KalVista's Net Loss Widens to $120.5M Amid Sebetralstat Push
— Jul 10, 2025 Risk: high
KalVista Pharmaceuticals, Inc. reported a net loss of $120.5 million for the fiscal year ended April 30, 2025, a significant increase from the $105.2 million ne -
KalVista Pharma Files 2024 10-K
— Jul 11, 2024 Risk: medium
KalVista Pharmaceuticals, Inc. filed its 2024 10-K report on July 11, 2024, detailing its fiscal year ending April 30, 2024. The company, formerly known as Carb
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX